Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Knight Therapeutics Inc (OP: KHTRF )

4.150 +0.180 (+4.53%)
Streaming Delayed Price Updated: 3:58 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,200
Open 4.170
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 3.970
Today's Range 4.140 - 4.173
52wk Range 3.201 - 4.410
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Ardelyx is A Buy After Slip in Early 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them 
Via MarketBeat
Exposures Product Safety
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF) 
Via Benzinga

Performance

YTD
+7.07%
+7.07%
1 Month
N/A
N/A
3 Month
+7.01%
+7.01%
6 Month
+4.80%
+4.80%
1 Year
+14.64%
+14.64%

More News

Read More
Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.